Authors' reply to Schaffalitzky de Muckadell and colleague's Comment on "Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017".

Drug Saf

Vifor Pharma Management Ltd., Flughofstrasse 61, 8152, Glattbrugg, Switzerland.

Published: May 2019

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475511	PMC
http://dx.doi.org/10.1007/s40264-019-00815-4	DOI Listing

Publication Analysis

authors' reply

reply schaffalitzky

schaffalitzky muckadell

muckadell colleague's

colleague's comment

comment "evaluation

"evaluation reported

reported rates

rates severe

severe hypersensitivity

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!